Lymph fluid study aims to unlock secrets of MS treatment
NCT ID NCT05162638
First seen Jan 11, 2026 · Last updated May 01, 2026 · Updated 20 times
Summary
This study collects lymph fluid from the chest of 24 people (some with multiple sclerosis, some healthy) to compare immune cells in the lymph system versus the blood. For MS participants, fluid is collected before and after starting ofatumumab, an approved MS drug. The goal is to learn how the drug affects immune cells deep in the body, not to provide direct treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.